The ratings of three Medical Devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Rockwell Medical Inc (NASDAQ:RMTI) earns an F (“strong sell”) this week, moving down from last week’s grade of D (“sell”). Rockwell Medical Technologies manufactures hemodialysis concentrate solutions and dialysis kits. In Portfolio Grader’s specific subcategories of Earnings Revisions, Equity, and Cash Flow, RMTI also gets an F. The stock price has fallen 16.6% over the past month, worse than the 2.5% increase the Nasdaq has seen over the same period of time. For a full analysis of RMTI stock, visit Portfolio Grader.
Accuray’s (NASDAQ:ARAY) rating falls to a D (“sell”) this week, down from C (“hold”) the week prior. Accuray designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. The stock receives F’s in Earnings Revisions, Equity, Cash Flow, and Sales Growth. Wall Street appears to agree with the stock downgrade, with share prices dropping 25.7% over the past month. For more information, get Portfolio Grader’s complete analysis of ARAY stock.
This week, Abiomed’s (NASDAQ:ABMD) rating worsens to a D from the company’s C rating a week ago. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. As of Feb. 1, 2013, 19.2% of outstanding Abiomed shares were held short. The stock currently has a trailing PE Ratio of 38.40. To get an in-depth look at ABMD, get Portfolio Grader’s complete analysis of ABMD stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.